AFIB

NASDAQ

Acutus Medical Inc.

SectorHealth CareIndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusIPO2020

$0.09-0.04 (-28.15%)

News25/Ratings7

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is based in Carlsbad, California.

Price$0.09+0.00 (+0.00%)

2025-04-242025-05-07

Latest news

25 items

395dSEC
SEC Form 10-K filed by Acutus Medical Inc.
10-K - Acutus Medical, Inc. (0001522860) (Filer)
395dSEC
Acutus Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Acutus Medical, Inc. (0001522860) (Filer)
395dPR
Acutus Medical Reports Full Year 2024 Financial Results
CARLSBAD, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (OTC:AFIB) today reported results for the full year of 2024. Recent Highlights: 2024 Revenue from Continuing Operations of $20.2 million grew 181% year-over-year, from $7.2 million last year.Operating loss for continuing operations was $0.1 million, compared to 11.7 million last year.Recorded $10.8 million in gain on sale of business, an increase of 19% compared to last year.Cash, cash equivalents, marketable securities and restricted cash were $14.0 million as of December 31, 2024. Full Year 2024 Financial ResultsRevenue from Continuing Operations was $20.2 million for 2024, an increas
450dINSIDER
SEC Form 4 filed by Director by deputization Flynn James E
4 - Acutus Medical, Inc. (0001522860) (Issuer)
450dSEC
Amendment: SEC Form SCHEDULE 13D/A filed by Acutus Medical Inc.
SCHEDULE 13D/A - Acutus Medical, Inc. (0001522860) (Subject)
454dSEC
SEC Form 15-15D filed by Acutus Medical Inc.
15-15D - Acutus Medical, Inc. (0001522860) (Filer)
455dSEC
SEC Form EFFECT filed by Acutus Medical Inc.
EFFECT - Acutus Medical, Inc. (0001522860) (Filer)
455dSEC
SEC Form EFFECT filed by Acutus Medical Inc.
EFFECT - Acutus Medical, Inc. (0001522860) (Filer)
455dSEC
Amendment: SEC Form SCHEDULE 13D/A filed by Acutus Medical Inc.
SCHEDULE 13D/A - Acutus Medical, Inc. (0001522860) (Subject)
457dSEC
SEC Form S-8 POS filed by Acutus Medical Inc.
S-8 POS - Acutus Medical, Inc. (0001522860) (Filer)
457dSEC
SEC Form S-8 POS filed by Acutus Medical Inc.
S-8 POS - Acutus Medical, Inc. (0001522860) (Filer)
457dSEC
SEC Form S-8 POS filed by Acutus Medical Inc.
S-8 POS - Acutus Medical, Inc. (0001522860) (Filer)
457dSEC
SEC Form S-8 POS filed by Acutus Medical Inc.
S-8 POS - Acutus Medical, Inc. (0001522860) (Filer)
457dSEC
SEC Form S-8 POS filed by Acutus Medical Inc.
S-8 POS - Acutus Medical, Inc. (0001522860) (Filer)
457dSEC
SEC Form POS AM filed by Acutus Medical Inc.
POS AM - Acutus Medical, Inc. (0001522860) (Filer)
457dSEC
SEC Form POS AM filed by Acutus Medical Inc.
POS AM - Acutus Medical, Inc. (0001522860) (Filer)
457dSEC
Acutus Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Other Events, Financial Statements and Exhibits
8-K - Acutus Medical, Inc. (0001522860) (Filer)
493d13D/G
Amendment: SEC Form SC 13D/A filed by Acutus Medical Inc.
SC 13D/A - Acutus Medical, Inc. (0001522860) (Subject)
505dSEC
Acutus Medical Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Acutus Medical, Inc. (0001522860) (Filer)
505dPR
Acutus Medical Announces Operational Downsizing
CARLSBAD, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), today announced a realignment of resources and operational downsizing. Dr. Shaden Marzouk, Chairperson of the Board of Directors of Acutus, commented, "Following an extensive strategic review by the Company's Board of Directors, we are taking the hard but necessary steps to reduce the size of our organization while complying with our remaining obligations to Medtronic for the production of left-heart access products." Takeo Mukai, CEO & CFO of Acutus, added, "The operational downsizing impacts our team, and it is difficult to part with our valued and highly talented colleag
524dSEC
Acutus Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - Acutus Medical, Inc. (0001522860) (Filer)
525dSEC
SEC Form 10-Q filed by Acutus Medical Inc.
10-Q - Acutus Medical, Inc. (0001522860) (Filer)
525dSEC
Acutus Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Acutus Medical, Inc. (0001522860) (Filer)
525dPR
Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results
CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (OTC:AFIB) today reported results for the third quarter and year-to-date of 2024. Recent Highlights: Third quarter revenue from Continuing Operations of $5.3 million grew 156% year-over-year, from $2.1 million in the same quarter last year.Operating income for continuing operations was $0.1 million, an improvement of 119% compared to the same period last year.Recorded $2.4 million in gain on sale of business, a decrease of 8% compared to the same period last year.Cash, cash equivalents, marketable securities and restricted cash were $12.6 million as of September 30, 2024. Thi
525d13D/G
Amendment: SEC Form SC 13G/A filed by Acutus Medical Inc.
SC 13G/A - Acutus Medical, Inc. (0001522860) (Subject)